Oncology evaluation directory Neuro-oncology

Brain Tumor Evaluation

A neuro-oncology review for primary brain tumors or brain metastases, organized around MRI findings, pathology or molecular profile, neurological symptoms, steroid/anti-seizure use and prior surgery, radiation or systemic therapy.

MRI-based reviewNeurological statusMolecular profile
Medical disclaimer: This page is informational and coordination-focused. It does not diagnose, prescribe, promise treatment suitability or replace urgent local medical care.
Clinical file logic

What the specialist needs to understand before any treatment discussion.

Brain tumor coordination requires particular caution because symptoms can change quickly. The first step is to clarify whether the file concerns a primary brain tumor, a brain metastasis from another cancer or an uncertain lesion.

The review includes neurological symptoms, steroid dependence, seizure history, surgical/radiation details and whether urgent local treatment is needed before any international coordination.

01

Diagnosis category

Primary brain tumor, metastasis, recurrence, radiation necrosis or uncertain lesion is clarified.

02

MRI details

Recent contrast MRI, lesion number, edema, mass effect and progression compared with prior scans are reviewed.

03

Pathology/molecular profile

Histology, IDH, MGMT, 1p/19q or other markers are included when available.

04

Neurological status

Seizures, weakness, speech changes, vision, cognition, headaches and steroid need are documented.

05

Prior treatment

Surgery, radiation, radiosurgery, temozolomide, immunotherapy or systemic therapy are summarized.

06

Urgency and travel safety

Risk of rapid deterioration is assessed before any non-local planning.

Evaluation matrix

How the case is reviewed without reducing it to a diagnosis name.

Each item below affects how the file is interpreted, what the physician can answer and whether additional documents are needed before a responsible response.

01

Neurological safety

New deficits or seizures may require immediate local care.

02

Primary vs metastasis

Treatment logic differs greatly depending on tumor origin.

03

Imaging chronology

Serial MRI comparison is often more useful than one scan alone.

04

Steroid dependence

High-dose steroids, edema and infection risk affect suitability and travel.

Documents to prepare

A complete medical file prevents delay and unrealistic expectations.

Most delays happen when the diagnosis is described verbally but the file lacks dates, reports, imaging, pathology or the current specialist recommendation. The documents below are requested before the file is considered ready for review.

MRI reportsRecent and prior MRI brain with contrast reports and images when available.
Pathology/molecularSurgery/biopsy pathology and molecular markers.
Treatment historySurgery, radiation, radiosurgery, systemic therapy and dates.
Neurology statusSeizure history, anti-seizure medication, steroids and neurological exam notes.
Primary cancer recordsIf metastasis, records from the original cancer diagnosis and treatments.
Current specialist noteNeurosurgery/neuro-oncology recommendation and clinical question.
Cuba context

How Cuba-related options are framed responsibly.

The page does not present a hospital visit or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.

01

Urgency is prioritized

Neurological instability is not managed by travel planning; it requires local medical care.

02

Specialist routing may be mixed

Neuro-oncology, neurosurgery, radiation oncology and medical oncology may all be relevant.

03

File clarity protects the patient

The review avoids vague promises when diagnosis or progression is uncertain.

When local care comes first

Do not wait for international review if urgent symptoms are present.

International coordination should never delay emergency care. If any of the following are present, the patient should be assessed locally first.

  • New seizure, confusion, severe headache, vomiting or loss of consciousness.
  • New weakness, speech difficulty, vision changes or balance problems.
  • Rapidly increasing steroid need or signs of raised intracranial pressure.
Coordination pathway

From records to written next steps.

  1. File intakeReports, imaging, summaries and current symptoms are uploaded through the application flow.
  2. Quality checkThe coordination team checks readability, dates, translation needs and missing items.
  3. Specialist routingThe case is prepared around a clear medical question and routed to the relevant review pathway.
  4. Written responseThe patient receives an organized next-step explanation before travel, payment or treatment logistics are considered.
Questions

Before starting the application.

Does this page mean I am suitable for a Cuba-based treatment?

No. It explains how the file is organized for review. Suitability, route, timing and safety can only be determined by physicians after reviewing the complete current record.

Can I send only a short summary?

A summary helps, but it is not enough for most oncology reviews. Pathology, imaging, treatment history, lab results and the latest oncology note are usually needed.

Will the coordinator choose my treatment?

No. Cuba Health Assist coordinates records, communication, translation support and logistics. Medical decisions remain with licensed physicians and the patient’s treating team.

What happens if my file is incomplete?

The team will request missing reports before presenting the case as ready. This protects the patient from receiving a weak or unrealistic response.

Can urgent symptoms be handled through this page?

No. Severe or rapidly worsening symptoms require local emergency or oncology care first. International coordination is not an emergency service.

Start with the file

Submit documents before making a travel or treatment decision.

A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.